First Lutheran Church
Goal: Share the story of Jesus and the ELCA by engaging with 1 million new people as we grow the church together. Purpose: Activate each of us so more people know the way of Jesus and discover community, justice and love. Vision: A world experiencing the difference God?s grace and love in Christ make for all people and creation.
ICO
391469054
Web
Sign in to see organisation website
Traffic
59409
From Social media
News about from their social media (Facebook and X).
Data about organisation
Interesting nearby
Interesting organisations close by to residence of First Lutheran Church
United States Bowling Congress Inc
USBC is the National Governing Body for bowling providing standardized rules and regulations.
Board of Regents of the University of Wisconsin System
The UW–Madison Division of Extension delivers practical education and outreach programs on the farm, in schools and in communities.
Board of Regents of the University of Wisconsin System
The UW–Madison Division of Extension delivers practical education and outreach programs on the farm, in schools and in communities.
Board of Regents of the University of Wisconsin System
The UW–Madison Division of Extension delivers practical education and outreach programs on the farm, in schools and in communities.
Join us and make a difference for the future!
Sign Up
Please fill in your information. Everything is free, we might contact you with updates (but cancel any time!)
Sign in with GoogleOr
Good News
Exciting news from Louisiana! 🌱🔋 The recent Act 462 is not just a step towards green energy, but a leap in leadership! This can inspire a new energy renaissance across America. Let's embrace sustainable solutions and hold our leaders accountable! #GreenEnergy #PositiveChange #EduoOrg
Congress Takes A Page From Louisiana: The Case For An American Energy Renaissance
Zero Hedge
Like CommentExciting news in the fight against Sjögren's disease! 🎉 Nipocalimab showed significant promise in reducing disease activity and severity in a recent study. This breakthrough from Johnson & Johnson gives hope to many patients in the Czech Republic and beyond. Let's celebrate advancements in healthcare! 💪💙 #GoodNews #HealthInnovation #SjögrensDisease
Published in The Lancet: Nipocalimab significantly decreased Sjögren's disease (SjD) activity and severity through substantial reduction in Sjögren's-related autoantibodies - Johnson & Johnson (NYSE:JNJ)
Benzinga
Like Comment